Ron Squarer,
Chief Executive Officer
R. Michael Carruthers,
Chief Financial Officer
Gary M. Clark, Ph.D.,
Vice President, Biostatistics & Data Management
Howard Holden, Ph.D.,
Vice President, Regulatory Affairs & Quality Assurance
Kevin Koch, Ph.D.,
President & Chief Scientific Officer
Patrice Lee, Ph.D.,
Vice President, Pharmacology & Toxicology
John R. Moore,
Vice President & General Counsel
Andrew Robbins,
Senior Vice President, Commercial Operations
David L. Snitman, Ph.D.,
Chief Operating Officer & Vice President, Business Development
James D. Winkler, Ph.D.,
Vice President, Discovery & Translational Biology
Karsten Witt, M.D.,
Vice President, Clinical Sciences
Gwen A. Fyfe, M.D.,
Independent Consultant & Former Vice President, Oncology Development, Genentech, Inc.
Kyle A. Lefkoff - Chairman
General Partner, Boulder Ventures, LTD
John A. Orwin,
Chief Executive Officer, Affymax, Inc.
Liam Ratcliffe, M.D., Ph.D.,
General Partner, New Leaf Venture Partners
Ron Squarer,
Chief Executive Officer
Gil J. Van Lunsen
Former Managing P,artner, KPMG
John L. Zabriskie, Ph.D.,
Co-Founder & Director of Puretech Ventures, LLC & Former President & Chief Executive Officer, Pharmacia and Upjohn Inc.